STERIS plc (STE) Financials
Key financial figures for STERIS plc (Q2 2027).
STERIS raised fiscal 2027 adjusted EPS guidance to $11.35-$11.55 from $11.10-$11.30, including about $0.18 from tariff refunds, after Q2 revenue rose 9% to $1,588.6M. Q2 FY2027 revenue was $1,588.6M versus $1,460.3M a year earlier (+8.8% as reported, +8.1% constant currency organic); adjusted EPS was $2.94 versus $2.47 and GAAP diluted EPS was $2.19 versus $1.94. Life Sciences led: revenue $170.6M versus $145.0M (+17.7% as reported), with capital equipment up 53%; segment operating income rose to $75.8M from $59.9M. Healthcare revenue was $1,122.4M versus $1,033.8M (+8.6%), and AST revenue was $295.6M versus $281.5M (+5.0%) with AST capital equipment down 21%. On the outlook: FY2027 adjusted EPS now $11.35-$11.55 (prior $11.10-$11.30), including about $0.18 from tariff refunds received year-to-date; as reported revenue growth of 7-8% and constant currency organic growth of 6-7% unchanged; segment constant currency organic growth: Healthcare 6-7% (unchanged), AST 6-7% (prior 7-8%), Life Sciences 9-10% (prior 6-7%); capex about $450M and free cash flow about $800M (set in August, unchanged); outlook excludes the proposed Xodus Medical acquisition. Figures are for Q2 FY2027, as Steris plc reported them.
- Revenue
- $1.6B
- Net Income
- $214M
- EPS
- $2.20
- Total Assets
- $10.7B
- Operating Cash Flow
- $289M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2027 | $1.6B | $214M | $2.19 | 18.52% | $213M |
| Q1 FY2027 | $1.5B | $200M | $2.04 | 19.15% | $280M |
| Q4 FY2026 | $1.6B | $220M | $2.24 | 19.94% | $245M |
| Q3 FY2026 | $1.5B | $193M | $1.96 | 18.11% | $200M |
| Q2 FY2026 | $1.5B | $192M | $1.94 | 18.35% | $201M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $5.9B | $785M | $7.93 | 18.56% | $972M |
| FY2025 | $5.5B | $615M | $6.20 | 15.87% | $778M |
| FY2024 | $5.1B | $378M | $3.81 | 16.27% | $613M |
Frequently asked questions
What was Steris plc's revenue last quarter?
Steris plc reported revenue of $1.59 billion for Q2 FY2027, up 8.8% from the same period a year earlier.
Is Steris plc profitable?
Yes. Steris plc reported net income of $213.7 million for Q2 FY2027, a net margin of 13.45% on revenue.
How has Steris plc's margin trended?
Operating margin was 18.52% in Q2 FY2027, compared with 18.35% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Steris plc generate?
Steris plc generated free cash flow of $212.7 million in Q2 FY2027, after capital expenditure.
Full income statement, balance sheet and cash flow for STERIS plc on SentiSense, with up to forty quarters and twenty fiscal years of history.